期刊文献+

不同剂量(150mg/d与75mg/d)氯吡格雷治疗30d对患者血小板聚集的影响:随机、双盲研究 被引量:2

A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days
下载PDF
导出
摘要 目的:探讨是否增加氯吡格雷维持剂量能增强对血小板聚集的抑制作用。方法和结果:60例经600mg氯吡格雷预治疗的患者在接受成功PCI术后12h内被纳入研究,以随机、双盲方式分为两组,分别接受氯吡格雷75mg/d或150mg/d治疗。PCI术后30d,分别采用光学聚集度测定和即时检测(VerifyNowTMP2Y12)方法测量血小板功能。 Aims: We sought to test whether an increase in the clopidogrel maintenance dose results in increased inhibition of platelet aggregation. Methods and results: Sixty patients after pretreatment with 600 mg of clopidogrel and within 12 h after successful PCI were included in this trial. They were allocated to receive one of two clopidogrel daily maintenance doses(75 or 150 mg) for 30 days in a double-blind randomized manner. Platelet function was evaluated 30 days after the intervention with optical aggregomet...
机构地区 [
  • 相关文献

同被引文献41

  • 1KUNAPULI S P, DORSAM R T, KIM S, et al. Platelet purinergic receptors [ J ]. Curr Opin Pharmacol , 2003,3 (1) :175-180. 被引量:1
  • 2WIVIOTT S D, ANTMAN E M. Clopidogrel resistance:a new chapter in a fastmoving story [ J ]. Circulation, 2004, 9( 13 ) :3064-3067. 被引量:1
  • 3SLOTTOW T P, BONELLO L, GAVINI R, et al. Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting atent thrombosis [ J]. Am J Cardiol,2009,104 ( 3 ) :525-530. 被引量:1
  • 4SEREBRUANY V, CHERALA G, WOLLIAMS C, et al. Association of platelet responsiveness with clopidogrel metabolism: role of compliance in the assessment of "resistance" [J]. Am Heart J, 2009,158(8) :925-932. 被引量:1
  • 5TAUBERT D, KASTRATI A, HARLFINGER S, et al. Pharmacokinetics of clopidogrel after administration of a high loading dose [ J]. Thromb haemost, 2004, 92 ( 2 ) : 311 - 316. 被引量:1
  • 6LAU W C, GURBEL P A, WATKINS P B, et al. Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance [ J ]. Circulation, 2004,109 ( 2 ) : 166-171. 被引量:1
  • 7SAW J, BRENNAN D M, STEINHUBL S R, et al. Lack of evidence of a clopidogrelstatin interaction in the CHARISMA trial[ J]. J Am Coll Cardiol , 2007,50 (2) : 291-295. 被引量:1
  • 8HOP M, MADDOXT M, WANG L, et al. Risk ofadvoutcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome[ J ]. JAMA ,2009,301 (6) :937-944. 被引量:1
  • 9SILLER-MATULA J M, LANG I, CHRIST G, et al. Calcium-channel blockers reduce the antiplatelet effect of clopidogrel [J]. J Am Coll Cardiol, 2008,52(10) : 1557- 1563. 被引量:1
  • 10SOFFER D, MOUSSA I, HARJAI K J, et al. Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention:do we need more aggressive dosing regimens in unstable angina? [ J ]. Cathet Cardiovasc Interv, 2003,59 ( 1 ) :21-25. 被引量:1

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部